Study identifies toxic key to Alzheimer’s disease memory loss

June 26, 2008

Using new scientific techniques, scientists have unlocked the cascade of molecular events that lead to Alzheimer’s disease. The scientific findings published in the latest edition of Nature Medicine suggest a potential new target for the development of drug therapies to fight the irreversible and degenerative disease which affects some 29.8 million people worldwide. The total worldwide societal cost of dementia was estimated at somewhere in the region of US$315.4 billion in 2005.

Alzheimer's disease is marked by the build-up of plaques consisting of beta-amyloid protein fragments, as well as abnormal tangles of tau protein found inside brain cells. Early in the disease, Alzheimer's pathology is first observed in the hippocampus, the part of the brain important to memory, and gradually spreads to the cerebral cortex, the outer layer of the brain.

The team of Irish and international researchers have identified that the accumulation of a particular protein (called amyloid ß-protein - Aß) in the brain initiates Alzheimer’s disease and that it directly alters the structure and function of brain cells. The findings place a significant emphasis on the development of new therapeutic strategies targeted at the reduction of the formation of Aß as opposed to the reduction of the plaque burden associated with the disease.

“Alzheimer’s disease is a major personal and societal tragedy,” says Professor Ciaran Regan from the UCD School of Biomolecular and Biomedical Science, University College Dublin, one of the co-authors of the report. “The disease progression is torturously long and debilitating, extorting a huge emotional and economic cost.”

“The onset of the disease is insidious with the earliest symptoms often manifested as subtle and intermittent deficits of episodic memory,” explains Professor Dominic Walsh, associate Professor of Pharmacology at the UCD Conway Institute, University College Dublin, another co-author of the report.

“Our findings support the growing theory that Alzheimers’s disease memory deficits may result from loss of dendritic spines and that this process is mediated by amyloid ß–protein (Aß) oligomers, not monomer or plaque Aß as previously considered.”

Source: University College Dublin

Explore further: Elevating brain protein allays symptoms of Alzheimer's and improves memory

Related Stories

Basic research fuels advanced discovery

August 26, 2016

Clinical trials and translational medicine have certainly given people hope and rapid pathways to cures for some of mankind's most troublesome diseases, but now is not the time to overlook the power of basic research, says ...

Recommended for you

How the finch changes its tune

August 3, 2015

Like top musicians, songbirds train from a young age to weed out errors and trim variability from their songs, ultimately becoming consistent and reliable performers. But as with human musicians, even the best are not machines. ...

Cow embryos reveal new type of chromosome chimera

May 27, 2016

I've often wondered what happens between the time an egg is fertilized and the time the ball of cells that it becomes nestles into the uterine lining. It's a period that we know very little about, a black box of developmental ...

Shaving time to test antidotes for nerve agents

February 29, 2016

Imagine you wanted to know how much energy it took to bike up a mountain, but couldn't finish the ride to the peak yourself. So, to get the total energy required, you and a team of friends strap energy meters to your bikes ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.